In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features

Mingli Xiang1 The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, People’s Republic of ChinaCorrespondence[email protected]

Kai Lei1 The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, People’s Republic of China

Wenjie Fan1 The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, People’s Republic of China

Yuchun Lin2 Department of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, USA

Gu He1 The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, People’s Republic of China

Mingli Yang3 Institute of Atomic and Molecular Physics, Sichuan University, Chengdu, People’s Republic of China

Lijuan Chen1 The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, People’s Republic of China

Yirong Mo4 Department of Chemistry, Western Michigan University, Kalamazoo, MI, USA

show all

In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date